Neural markers of genetic vulnerability to drug addiction

Current Topics in Behavioral Neurosciences

Volumn 3, Issue , 2010, Pages 277-299

  Müller, Daniel J ^a,b   Likhodi, Olga ^b   Heinz, Andreas ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alcohol dependence; Association studies; Brain reward system; Genetics; Genome wide studies; Nicotine dependence

Indexed keywords

ALCOHOL; ILLICIT DRUG; NALTREXONE; NICOTINE; PLACEBO; BIOLOGICAL MARKER;

ALCOHOLISM; ARTICLE; BRAIN DYSFUNCTION; BRAIN FUNCTION; COMORBIDITY; DISEASE ASSOCIATION; DRUG TRAFFIC; ENDOPHENOTYPE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HERITABILITY; HUMAN; LINKAGE ANALYSIS; NEUROIMAGING; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REWARD; SOCIOECONOMICS; TOBACCO DEPENDENCE; ADDICTION; ANIMAL; BRAIN; GENETICS; PATHOLOGY; REVIEW;

ANIMALS; BEHAVIOR, ADDICTIVE; BIOLOGICAL MARKERS; BRAIN; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 79952115465     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2009_25     Document Type: Article

References (110)

1. Agrawal A, Lynskey MT (2008) Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction 103:1069-1081
2. Ait-Daoud N, Johnson BA, Prihoda TJ, Hargita ID (2001) Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence. Psychopharmacology (Berl) 154:23-27
3. Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65:135-144
4. Ball D (2008) Addiction science and its genetics. Addiction 103:360-367
5. Bennett AJ, Lesch KP, Heils A, Long JC, Lorenz JG, Shoaf SE, Champoux M, Suomi SJ, Linnoila MV, Higley JD (2002) Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry 7:118-122
6. Benowitz NL (2008) Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med 121:S3-S10
7. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28:309-369
8. Canli T, Lesch KP (2007) Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci 10:1103-1109
9. Canli T, Qiu M, Omura K, Congdon E, Haas BW, Amin Z, Herrmann MJ, Constable RT, Lesch KP (2006) Neural correlates of epigenesis. Proc Natl Acad Sci USA 103:16033-16038
10. Caron L, Karkazis K, Raffin TA, Swan G, Koenig BA (2005) Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking. Nicotine Tob Res 7:181-197
11. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389
12. Ceballos NA (2006) Tobacco use, alcohol dependence, and cognitive performance. J Gen Psychol 133:375-388
13. Dawson DA, Li TK, Grant BF (2008) A prospective study of risk drinking: at risk for what? Drug Alcohol Depend 95:62-72
14. Dick DM, Foroud T (2003) Candidate genes for alcohol dependence: a review of genetic evidence from human studies. Alcohol Clin Exp Res 27:868-879
15. Doudet D, Hommer D, Higley JD, Andreason PJ, Moneman R, Suomi SJ, Linnoila M (1995) Cerebral glucose metabolism, CSF 5-HIAA levels, and aggressive behavior in rhesus monkeys. Am J Psychiatry 152:1782-1787
16. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR (2006) Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry 63:1396-1406
17. Ducci F, Enoch MA, Hodgkinson C, Xu K, Catena M, Robin RW, Goldman D (2008) Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. Mol Psychiatry 13:334-347
18. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922
19. Enoch MA (2006) Genetic and environmental influences on the development of alcoholism: resilience vs. risk. Ann N Y Acad Sci 1094:193-201
20. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D (2003) Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 13:33-41
21. Enoch MA, White KV, Waheed J, Goldman D (2008) Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders. Depress Anxiety 25:383-392
22. Froehlich JC, Zink RW, Li TK, Christian JC (2000) Analysis of heritability of hormonal responses to alcohol in twins: beta-endorphin as a potential biomarker of genetic risk for alcoholism. Alcohol Clin Exp Res 24:265-277
23. Gallinat J, Meisenzahl E, Jacobsen LK, Kalus P, Bierbrauer J, Kienast T, Witthaus H, Leopold K, Seifert F, Schubert F, Staedtgen M (2006) Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci 24:1744-1750
24. Gallinat J, Bauer M, Heinz A (2008) Genes and neuroimaging: advances in psychiatric research. Neurodegener Dis 5:277-285
25. Goldman D, Oroszi G, Ducci F (2005) The genetics of addictions: uncovering the genes. Nat Rev Genet 6:521-532
26. Goldstein DB (2005) The genetics of human drug response. Philos Trans R Soc Lond B Biol Sci 360:1571-1572
27. Gorwood P, Wohl M, Le Strat Y, Rouillon F (2007) Gene-environment interactions in addictive disorders: epidemiological and methodological aspects. C R Biol 330:329-338
28. Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636-645
29. Gunne LM, Änggard E, Jönson LE (1972) Clinical trails with amphetamine-blocking drugs. Psychiat Neurol Neurochir (Amst) 75:225-226
30. Han C, McGue MK, Iacono WG (1999) Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: univariate and multivariate behavioral genetic analyses. Addiction 94:981-993
31. Hariri AR, Weinberger DR (2003) Imaging genomics. Br Med Bull 65:259-270
32. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400-403
33. Harris GJ, Jaffin SK, Hodge SM, Kennedy D, Caviness VS, Marinkovic K, Papadimitriou GM, Makris N, Oscar-Berman M (2008) Frontal white matter and cingulum diffusion tensor imaging deficits in alcoholism. Alcohol Clin Exp Res 32:1001-1013
34. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict 86:1119-1127
35. Heinz A, Smolka MN (2006) The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev Neurosci 17:359-367
36. Heinz A, Higley JD, Gorey JG, Saunders RC, Jones DW, Hommer D, Zajicek K, Suomi SJ, Lesch KP, Weinberger DR, Linnoila M (1998a) In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates. Am J Psychiatry 155:1023-1028
37. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M (1998b) Reduced central serotonin transporters in alcoholism. Am J Psychiatry 155:1544-1549
38. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133-139
39. Heinz A, Mann K, Weinberger DR, Goldman D (2001) Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res 25:487-495
40. Heinz A, Jones DW, Gorey JG, Bennet A, Suomi SJ, Weinberger DR, Higley JD (2003a) Serotonin transporter availability correlates with alcohol intake in non-human primates. Mol Psychiatry 8:231-234
41. Heinz A, Schäfer M, Higley JD, Krystal JH, Goldman D (2003b) Neurobiological correlates of the disposition and maintenance of alcoholism. Pharmacopsychiatry 36(Suppl 3):S255-S258
42. Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grusser SM, Flor H, Braus DF, Buchholz HG, Grunder G, Schreckenberger M, Smolka MN, Rosch F, Mann K, Bartenstein P (2004) Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 161:1783-1789
43. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, Klein S, Grusser SM, Flor H, Schumann G, Mann K, Buchel C (2005a) Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 8:20-21
44. Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G, Dohmen BM, Braus DF, Schumann G, Machulla HJ, Bares R, Mann K (2005b) Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 62:57-64
45. Heinz A, Smolka MN, Braus DF, Wrase J, Beck A, Flor H, Mann K, Schumann G, Buchel C, Hariri AR, Weinberger DR (2007) Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry 61:1011-1014
46. Higley JD, Suomi SJ, Linnoila M (1991) CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys. Psychopharmacology (Berl) 103:551-556
47. Hinckers AS, Laucht M, Schmidt MH, Mann KF, Schumann G, Schuckit MA, Heinz A (2006) Low level of response to alcohol as associated with serotonin transporter genotype and high alcohol intake in adolescents. Biol Psychiatry 60:282-287
48. Ho MK, Tyndale RF (2007) Overview of the pharmacogenomics of cigarette smoking. Pharmacogenomics J 7:81-98
49. Jezierski G, Braun K, Gruss M (2006) Epigenetic modulation of the developing serotonergic neurotransmission in the semi-precocial rodent Octodon degus. Neurochem Int 48:350-357
50. Kalus P, Slotboom J, Gallinat J, Federspiel A, Gralla J, Remonda L, Strik WK, Schroth G, Kiefer C (2005) New evidence for involvement of the entorhinal region in schizophrenia: a combined MRI volumetric and DTI study. Neuroimage 24:1122-1129
51. Kauhanen J, Hallikainen T, Tuomainen TP, Koulu M, Karvonen MK, Salonen JT, Tiihonen J (2000) Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res 24:135-139
52. Kendler KS, Neale MC, Heath AC, Kessler RC, Eaves LJ (1994) A twin-family study of alcoholism in women. Am J Psychiatry 151:707-715
53. Kendler KS, Karkowski LM, Neale MC, Prescott CA (2000) Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 57:261-269
54. Kienast T, Heinz A (2006) Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 5:109-131
55. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, Terpstra J, Turner RA, Reus VI (1998) Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 155:373-379
56. Köhnke MD (2008) Approach to the genetics of alcoholism: a review based on pathophysiology. Biochem Pharmacol 75:160-177
57. Laucht M, Becker K, Frank J, Schmidt MH, Esser G, Treutlein J, Skowronek MH, Schumann G (2008) Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence. J Am Acad Child Adolesc Psychiatry 47:673-681
58. Lesch KP (2005) Alcohol dependence and gene x environment interaction in emotion regulation: is serotonin the link? Eur J Pharmacol 526:113-124
59. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531
60. Levinson DF (2006) The genetics of depression: a review. Biol Psychiatry 60:84-92
61. Li MD, Ma JZ, Beuten J (2004) Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin Genet 66:382-392
62. Littleton J, Barron S, Prendergast M, Nixon SJ (2007) Smoking kills (alcoholics)! shouldn't we do something about it? Alcohol Alcohol 42:167-173
63. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210
64. Madden PA, Heath AC (2002) Shared genetic vulnerability in alcohol and cigarette use and dependence. Alcohol Clin Exp Res 26:1919-1921
65. Maes HH, Woodard CE, Murrelle L, Meyer JM, Silberg JL, Hewitt JK, Rutter M, Simonoff E, Pickles A, Carbonneau R, Neale MC, Eaves LJ (1999) Tobacco, alcohol and drug use in eightto sixteen-year-old twins: the Virginia Twin Study of Adolescent Behavioral Development. J Stud Alcohol 60:293-305
66. Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS (1998) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 betacarbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44:1090-1098
67. Manolio TA, Brooks LD, Collins FS (2008) A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118:1590-1605
68. Mereu G, Fadda F, Gessa GL (1984) Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats. Brain Res 292:63-69
69. Mereu G, Yoon KW, Boi V, Gessa GL, Naes L, Westfall TC (1987) Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 141:395-399
70. Meyerhoff DJ, Tizabi Y, Staley JK, Durazzo TC, Glass JM, Nixon SJ (2006) Smoking comorbidity in alcoholism: neurobiological and neurocognitive consequences. Alcohol Clin Exp Res 30:253-264
71. Müller DJ, Mandelli L, Serretti A, Deyoung CG, De Luca V, Sicard T, Tharmalingam S, Gallinat J, Muglia P, De Ronchi D, Jain U, Kennedy JL (2008) Serotonin transporter gene and adverse life events in adult ADHD. Am J Med Genet B Neuropsychiatr Genet 147B:1461-1469
72. Munafo M, Clark T, Johnstone E, Murphy M, Walton R (2004) The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res 6:583-597
73. Neuhaus A, Bajbouj M, Kienast T, Kalus P, von Haebler D, Winterer G, Gallinat J (2006) Persistent dysfunctional frontal lobe activation in former smokers. Psychopharmacology (Berl) 186:191-200
74. NIAAA (2001-2002) NIAAA (National Institute of Alcohol Abuse and Alcoholism) 2001-2002: National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
75. Noble EP (2000) The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics 1:309-333
76. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49:881-887
77. Ohara K, Nagai M, Suzuki Y, Ochiai M, Ohara K (1998) No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res 80:145-148
78. Oscar-Berman M, Marinkovic K (2003) Alcoholism and the brain: an overview. Alcohol Res Health 27:125-133
79. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546-1552
80. Puls I, Mohr J, Wrase J, Priller J, Behr J, KitzrowW, Makris N, Breiter HC, Obermayer K, Heinz A (2008) Synergistic effects of the dopaminergic and glutamatergic system on hippocampal volume in alcohol-dependent patients. Biol Psychol 79:126-136
81. Ray LA, Hutchison KE (2007) Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 64:1069-1077
82. Reich T, Edenberg HJ, Goate A, Williams JT, Rice JP, Van Eerdewegh P, Foroud T, Hesselbrock V, Schuckit MA, Bucholz K, Porjesz B, Li TK, Conneally PM, Nurnberger JI Jr, Tischfield JA, Crowe RR, Cloninger CR, Wu W, Shears S, Carr K, Crose C, Willig C, Begleiter H (1998) Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 81:207-215
83. Reimold M, Smolka MN, Schumann G, Zimmer A, Wrase J, Mann K, Hu XZ, Goldman D, Reischl G, Solbach C, Machulla HJ, Bares R, Heinz A (2007) Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype. J Neural Transm 114:635-639
84. Retz W, Freitag CM, Retz-Junginger P, Wenzler D, Schneider M, Kissling C, Thome J, Rosler M (2008) A functional serotonin transporter promoter gene polymorphism increases ADHD symptoms in delinquents: interaction with adverse childhood environment. Psychiatry Res 158:123-131
85. Rose RJ (1998) A developmental behavior-genetic perspective on alcoholism risk. Alcohol Health Res World 22:131-143
86. Schmack K, Schlagenhauf F, Sterzer P, Wrase J, Beck A, Dembler T, Kalus P, Puls I, Sander T, Heinz A, Gallinat J (2008) Catechol-O-methyltransferase val(158)met genotype influences neural processing of reward anticipation. Neuroimage 42:1631-1638
87. Schuckit MA, Smith TL (1996) An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry 53:202-210
88. Schuckit MA, Mazzanti C, Smith TL, Ahmed U, Radel M, Iwata N, Goldman D (1999) Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biol Psychiatry 45:647-651
89. Schumann G (2007) Okey Lecture 2006: identifying the neurobiological mechanisms of addictive behaviour. Addiction 102:1689-1695
90. Schumann G, Johann M, Frank J, Preuss U, Dahmen N, Laucht M, Rietschel M, Rujescu D, Lourdusamy A, Clarke TK, Krause K, Dyer A, Depner M, Wellek S, Treutlein J, Szegedi A, Giegling I, Cichon S, Blomeyer D, Heinz A, Heath S, Lathrop M, Wodarz N, Soyka M, Spanagel R, Mann K (2008) Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Arch Gen Psychiatry 65:826-838
91. Sebat J (2007) Major changes in our DNA lead to major changes in our thinking. Nat Genet 39:S3-S5
92. Serretti A, Calati R, Mandelli L, De Ronchi D (2006) Serotonin transporter gene variants and behavior: a comprehensive review. Curr Drug Targets 7:1659-1669
93. SmolkaMN, Schumann G, Wrase J, Grusser SM, Flor H, Mann K, Braus DF, Goldman D, Buchel C, Heinz A (2005) Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 25:836-842
94. Smolka MN, Buhler M, Schumann G, Klein S, Hu XZ, Moayer M, Zimmer A, Wrase J, Flor H, Mann K, Braus DF, Goldman D, Heinz A (2007) Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry 12:307-317
95. Tiihonen J, Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, Salonen JT, Ryynanen OP, Koulu M, Karvonen MK, Pohjalainen T, Syvalahti E, Hietala J (1999) Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry 4:286-289
96. True WR, Heath AC, Scherrer JF, Xian H, Lin N, Eisen SA, Lyons MJ, Goldberg J, Tsuang MT (1999) Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms. Am J Med Genet 88:391-397
97. Tsankova N, Renthal W, Kumar A, Nestler EJ (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8:355-367
98. Tyndale RF (2003) Genetics of alcohol and tobacco use in humans. Ann Med 35:94-121
99. Uhl GR (2004) Molecular genetics of substance abuse vulnerability: remarkable recent convergence of genome scan results. Ann N Y Acad Sci 1025:1-13
100. Uhl GR, Drgon T, Johnson C, Fatusin OO, Liu QR, Contoreggi C, Li CY, Buck K, Crabbe J (2008) "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem Pharmacol 75:98-111
101. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP (1995) Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry 152:613-615
102. Walitzer KS, Dearing RL (2006) Gender differences in alcohol and substance use relapse. Clin Psychol Rev 26:128-148
103. Wang T, Franke P, Neidt H, Cichon S, Knapp M, Lichtermann D, Maier W, Propping P, Nothen MM (2001) Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach. Mol Psychiatry 6:109-111
104. WHO (2004) Global Status Report on Alcohol and Health
105. WHO (2008) The global tobacco crisis. WHO Report on the Global Tobacco Epidemic
106. Wilkes S (2008) The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis 3:45-53
107. Wrase J, Reimold M, Puls I, Kienast T, Heinz A (2006) Serotonergic dysfunction: brain imaging and behavioral correlates. Cogn Affect Behav Neurosci 6:53-61
108. Wrase J, Schlagenhauf F, Kienast T, Wustenberg T, Bermpohl F, Kahnt T, Beck A, Strohle A, Juckel G, Knutson B, Heinz A (2007) Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 35:787-794
109. Wrase J, Reimold M, Beck A, Heinz A (2008) Multimodal imaging with PET, fMRI and genetic research. Fortschr Neurol Psychiatr 76:278-285
110. Yamazaki H, Inoue K, Hashimoto M, Shimada T (1999) Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol 73:65-70